Clinical Trial Update: The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial assessing cannabidiol (CBD) for alcohol use disorder, focusing on efficacy and neurobehavioural mechanisms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Cannabidiol (CBD) (cannabidiol)

Snippet

Sponsor: South West Sydney Local Health District | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: UNKNOWN